AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial - PubMed
3 hours ago
- #lung cancer diagnosis
- #AI in healthcare
- #randomized controlled trial
- AI-based chest X-ray prioritization was tested in a randomized controlled trial to see if it reduced time to CT and lung cancer diagnosis.
- The study analyzed 93,326 CXRs, with no significant difference in median time to CT (53 days) or lung cancer diagnosis (44 vs 46 days) between AI-prioritized and non-prioritized groups.
- Discordance between AI and radiology reports occurred in 30.3% of cases, with actionable findings identified in 23.9% of discordant cases.
- The study concluded that AI prioritization of CXRs in primary care does not significantly impact the lung cancer diagnostic pathway and should not include worklist prioritization.
- Future research should focus on differentiating between primary pathway changes and the direct impact of AI.